MedTrace Logo

Rheumatologists and the Requesting of Antinuclear Antibodies (ANA) Tests in Patients With Rheumatologic Complaints

NCT02409251 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2015-04-06

No results posted yet for this study

Summary

The aim of this study is to assess the effect of a simple intervention (a combination of education and feedback) on Antinuclear Antibody (ANA) testing.

This aim was chosen because of the known overuse of many laboratory tests, of which ANA testing is one. As overuse of ANA tests can have negative consequences (both for patients and society), the investigators designed an intervention to see how this would influence Antinuclear Antibody testing by rheumatologists.

Conditions

  • Rheumatic Diseases

Interventions

BEHAVIORAL

Education and feedback

Sponsors & Collaborators

  • Sint Maartenskliniek

    lead OTHER

Principal Investigators

  • Ronald van Vollenhoven, MD, PhD · Karolinska Institutet

  • Marlies Hulscher, PhD · Scientific Institute for Quality of Healthcare, Radboud University Medical Center, Nijmegen, the Netherlands

  • Alfons den Broeder, MD, PhD · Sint Maartenskliniek, Nijmegen, the Netherlands

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-02-29
Primary Completion
2014-01-31
Completion
2014-07-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02409251 on ClinicalTrials.gov